Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-09

Clinical Trial Update: Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response [NA]

View source ↗

Summary

A completed clinical study evaluating the dosing of human rabies immunoglobulin (HRIG) and its effect on the development of an active immune response to rabies …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Rabies Immunoglobulin (HRIG) (rabies immunoglobulin)

Snippet

Sponsor: Queen Saovabha Memorial Institute | Conditions: Rabies | NA | Status: COMPLETED